Companies: 10,795·Total market cap: $144.5T
argenx SE

argenx SE

ARGXNASDAQHealthcare● Active
$883.20
$-8.12(-0.91%)
Market Cap$54.7B
P/E Ratio—
52W High$934.62
52W Low$510.055
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

argenx SE (ARGX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001697862 · ARGX · NASDAQ · as of Jun 8, 2026

Filing snapshot

275
Total Filings
6-K
Latest Form
2026-06-03
Most Recent
2017
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001697862 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-19
Fiscal Year End
Mar 19, 2026
Accession No.
0001697862-26-000032
Primary Document
argx-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001697862 · Accession 0001697862-26-000032

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-06-03
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-11
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-06
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-06
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-20
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-20
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-03-19
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-19
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-06
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-02-26
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-26
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-13
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-05
View
Showing 1–15 of 275 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001697862  |  Exchange: NASDAQ · Healthcare

argenx SE (NASDAQ: ARGX) has submitted 275 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001697862, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is argenx SE's most comprehensive regulatory disclosure. The most recent argenx SE 10-K was filed on 2026-03-19 for fiscal year ending 2026. Historical ARGX 10-K annual reports are available from 2017 through 2026.

Investors researching argenx SE SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
REGN SEC Filings →BDX SEC Filings →EW SEC Filings →CAH SEC Filings →IDXX SEC Filings →HLN SEC Filings →ALNY SEC Filings →A SEC Filings →
→ ARGX Financials→ ARGX Earnings→ ARGX Insider Trades

Frequently Asked Questions

ARGX SEC Filings · 8 questions

argenx SE (ARGX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 275 filings and access original documents at no cost. argenx SE's CIK is 0001697862.

ARGX SEC filingsargenx SE SEC documentsfind ARGX 10-K